Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steven Holtzman discusses partnering

R N. Lawrence1

  • 1Infinity Pharmaceuticals, 650 Albany Street, 02118, tel.: +1 617 8 59 9700x222; fax: +1 617 859 9703, Boston, MA, USA

Drug Discovery Today
|October 9, 2001
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

20 years on: Donald Francis discusses advances in the fight against HIV.

Drug discovery today·2001
Same author

Crispin Kirkman discusses the European biotech industry. Interviewed by Ben Ramster and Rebecca N. Lawrence.

Drug discovery today·2001
Same author

Erratum.

Drug discovery today·2001
Same author

Alastair Devlin discusses the concept of virtual pharma companies.

Drug discovery today·2001
Same author

Intelligent inhalers for systemic administration?

Drug discovery today·2001
Same author

Key industry directors and companies pick up awards.

Drug discovery today·2001
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles